Debra Ann Petit

Title: Debra Ann Petit: Innovator in Neurology-Related Proteins

Introduction

Debra Ann Petit is a notable inventor based in West Bridgewater, MA (US). She has made significant contributions to the field of neurology through her innovative research and inventions. Her work focuses on the detection and quantification of neu-related proteins in biological fluids, which has important implications for medical diagnostics.

Latest Patents

Debra Ann Petit holds a patent for her invention titled "Detection and quantification of neu related proteins in the biological fluids of humans." This invention relates to a substantially purified p100, a human neu-related protein with a molecular weight ranging from about 97,000 daltons to about 115,000 daltons. This protein corresponds substantially to the extracellular domain of the human neu gene product and is detectable in biological fluids. Additionally, her invention includes assays for detecting this protein and monoclonal antibodies capable of binding to p100.

Career Highlights

Debra Ann Petit is associated with Bayer Corporation, where she has contributed her expertise in the field of biotechnology. Her work has been instrumental in advancing the understanding of neu-related proteins and their potential applications in medical diagnostics.

Collaborations

Some of her notable coworkers include Walter P Carney and Paula Jean Marks, who have collaborated with her on various projects related to her research and inventions.

Conclusion

Debra Ann Petit is a pioneering inventor whose work in the detection of neu-related proteins has the potential to impact medical diagnostics significantly. Her contributions to the field highlight the importance of innovation in advancing healthcare solutions.